Skip to content

Abbott ABT Medical Devices — Operating Earnings

Other segment segments

Established Pharmaceuticals
$365M+22.5%
Diagnostic Products
$335M-6.7%
Nutritional Products
$311M-21.1%

Similar metrics at other companies

Becton, Dickinson and Company logo
BDXMedical — Segment Operating Income as a Percent of Revenues
9%+0.1pp
Zimmer Biomet Holdings logo
ZBHOperating Segments — Operating Income
$516.3M-1.4%
STERIS logo
STEOperatingSegmentAllExceptCorpandOther — Operating Income (Loss)
$229.63M+9.9%
Medtronic logo
MDTOther Operating Segments, Including Diabetes — Reportable segment operating profit
$26.5M-50.5%
Zimmer Biomet Holdings logo
ZBHProduct Category Operating Segments — Operating Income
$39.1M-8.4%
Mettler-Toledo International, Inc. logo
MTDOther Operations Segment — Segment profit
$27.54M+12.5%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's medical devices — operating earnings.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's medical devices — operating earnings?
Abbott (ABT) reported medical devices — operating earnings of $1.89B in Q1 2026.
How has Abbott's medical devices — operating earnings changed year-over-year?
Abbott's medical devices — operating earnings increased by 17.7% year-over-year, from $1.61B to $1.89B.
What is the long-term trend for Abbott's medical devices — operating earnings?
Over 4 years (2021 to 2025), Abbott's medical devices — operating earnings has grown at a 12.3% compound annual growth rate (CAGR), from $4.53B to $7.21B.
What does medical devices — operating earnings mean?
The profit earned from core business operations before interest and taxes.
How do you interpret medical devices — operating earnings?
An increase indicates improved profitability, better cost control, or higher sales volume.
How does medical devices — operating earnings compare across companies?
Standard operating profit metric used for segment reporting across all sectors.